Effect of tuberculosis–HIV co-treatment on clinical and growth outcomes among hospitalized children newly initiating antiretroviral therapy

MLA

Cherkos, Ashenafi S., et al. “Effect of Tuberculosis–HIV Co-Treatment on Clinical and Growth Outcomes among Hospitalized Children Newly Initiating Antiretroviral Therapy.” AIDS, vol. 38, no. 4, Mar. 2024, pp. 579–88. EBSCOhost, https://doi.org/10.1097/QAD.0000000000003797.

APA

Cherkos, A. S., Cranmer, L. M., Njuguna, I., LaCourse, S. M., Mugo, C., Moraa, H., Maleche-Obimbo, E., Enquobahrie, D. A., Richardson, B. A., Wamalwa, D., & John-Stewart, G. (2024). Effect of tuberculosis–HIV co-treatment on clinical and growth outcomes among hospitalized children newly initiating antiretroviral therapy. AIDS, 38(4), 579–588. https://doi.org/10.1097/QAD.0000000000003797

Chicago

Cherkos, Ashenafi S., Lisa M. Cranmer, Irene Njuguna, Sylvia M. LaCourse, Cyrus Mugo, Hellen Moraa, Elizabeth Maleche-Obimbo, et al. 2024. “Effect of Tuberculosis–HIV Co-Treatment on Clinical and Growth Outcomes among Hospitalized Children Newly Initiating Antiretroviral Therapy.” AIDS 38 (4): 579–88. doi:10.1097/QAD.0000000000003797.